medical cannabis
medical cannabis · page 29
- CBD Market
Global cannabis market projected to hit $100.4bn by 2026
Prohibition Partners has released The Global Cannabis Report: 3rd Edition, which cites the UK and Germany as key European medical cannabis markets.
- Medical
With lack of NHS cannabis prescriptions, UK doctors call for change
Doctors are calling for action following a new groundbreaking UK cannabis report from Volteface.
- Medical
Avida Global enters UK cannabis market
The company has acquired BCM Specials – the UK’s oldest specials manufacturer.
- Medical
New Zealand medical cannabis reaches Germany for the first time
Cantourage and CannFX have made the import.
- Adult-Use
Akanda completes first shipment of medical cannabis to Germany
Akanda has stated it is ready to serve legal adult-use markets in Europe once established.
- Companies
Cannabis clinic raises $3.5m to transform UK pain treatment
Óskare Capital and Weedmaps have made investments.
- Adult-Use
New Figures Show That 784 More Private Medical Cannabis Prescriptions Were Made In The UK Last Year Than Previously Thought
AS PLEA’s (Patient Lead Engagement for Access) Medical Cannabis Awareness Week (#MCAW2022) launches in the UK this week, fresh figures suggest growth in the number of privately prescribed, unlicensed medical cannabis items dispensed last year was even higher than previously thought.
- Companies
Stenocare enters Norway’s cannabis market with new agreement
The company has signed a deal with a leading distributor in Norway.
- Medical
European campaign to raise awareness of medical cannabis
The campaign has been launched by European specialty pharmaceutical company, Neuraxpharm, which is focused on the treatment of central nervous system disorders.
- Adult-Use
New report shows how Thailand is leading Asia in cannabis revolution
The report has been published by Prohibition Partners.
- Medical
One Year Extension To France’s Medical Cannabis Trial Makes Its Way Through Parliament
As reported in NewsWeed.fr LAST month France’s Directorate General of Health (DGS) pushed ahead with plans to extend the country’s medical cannabis trial by a minimum of one year without waiting for the results of the trial to be submitted to parliament.
- Medical
North Macedonian medical cannabis reaches German market
Cantourage is co-operating with Green Medicals Germany.
